The arrival of gene therapies: how can payers and pharma address the budget impact problem?

//The arrival of gene therapies: how can payers and pharma address the budget impact problem?

The arrival of gene therapies: how can payers and pharma address the budget impact problem?

A potential cure, but at what price?

The development of gene therapies represents a new frontier of science, with the potential to help many patients with serious or fatal conditions. These new treatments offer the possibility of a ‘cure’ for many devastating conditions, with remission rates of up to 94% demonstrated in severe cancer patients not responding to other available treatments.

Click here to read the full article

By |2018-06-08T08:50:29+00:00January 28th, 2018|News|0 Comments